PAVmed, Inc. (PAVM)
4.885
-0.10
(-1.91%)
USD |
NASDAQ |
Jun 11, 14:20
PAVmed Debt to Equity Ratio : 0.4304 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.4304 |
| December 31, 2025 | 0.393 |
| September 30, 2025 | 0.2594 |
| June 30, 2025 | 0.2282 |
| March 31, 2025 | 0.1966 |
| December 31, 2024 | -12.77 |
| September 30, 2024 | -7.174 |
| June 30, 2024 | -0.6766 |
| March 31, 2024 | -0.7224 |
| December 31, 2023 | -0.9051 |
| September 30, 2023 | -1.154 |
| June 30, 2023 | -1.528 |
| March 31, 2023 | -2.244 |
| December 31, 2022 | -3.784 |
| September 30, 2022 | 4.305 |
| June 30, 2022 | 1.484 |
| March 31, 2022 | 0.0649 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.006 |
| December 31, 2020 | 7.890 |
| September 30, 2020 | -1.591 |
| Date | Value |
|---|---|
| June 30, 2020 | -1.458 |
| March 31, 2020 | -1.378 |
| December 31, 2019 | -2.128 |
| September 30, 2019 | -2.370 |
| June 30, 2019 | -4.420 |
| March 31, 2019 | -1.516 |
| December 31, 2018 | -3.414 |
| September 30, 2018 | 0.8911 |
| June 30, 2018 | 0.4171 |
| March 31, 2018 | 9.080 |
| December 31, 2017 | -0.6826 |
| September 30, 2017 | -0.2677 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Lucid Diagnostics, Inc. | 6.701 |
| Alphatec Holdings, Inc. | 33.03 |
| SINTX Technologies, Inc. | 3.610 |
| PROCEPT BioRobotics Corp. | 0.2243 |
| Abbott Laboratories | 0.654 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 45.42M |
| Total Liabilities (Quarterly) | 20.43M |
| Shareholders Equity (Quarterly) | 39.52M |
| Current Ratio | 2.024 |
| Net Debt Paydown Yield | 31.76% |